Albumin Nitrosylated by Activated Macrophages Possesses Antiparasitic Effects Neutralized by Anti-NO-Acetylated-Cysteine Antibodies

Journal of Immunology

Volumn 158, Issue 1, 1997, Pages 308-314

  Mnaimneh, Sanié ^a,b   Geffard, Michel ^b   Veyret, Bernard ^b   Vincendeau, Philippe ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Laboratory of Physics   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIBODY; ANTITRYPANOSOMAL AGENT; NITRIC OXIDE; SERUM ALBUMIN;

ANIMAL; ARTICLE; BINDING COMPETITION; DRUG EFFECT; FEMALE; IMMUNOLOGY; MACROPHAGE ACTIVATION; METABOLISM; MOUSE; NITROSATION; PERITONEUM MACROPHAGE; TRYPANOSOMA;

ACETYLCYSTEINE; ANIMALS; ANTIBODIES; BINDING, COMPETITIVE; FEMALE; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; NITRIC OXIDE; NITROSATION; SERUM ALBUMIN; TRYPANOCIDAL AGENTS; TRYPANOSOMA;

EID: 0030637225     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Knowles, R. G., and S. Moncada. 1992. Nitric oxide as a signal in blood vessels. Trends Biochem. Sci. 17:399.
2. Kubes, P., M. Suzuki, and D. N. Granger. 1991. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA 88:4651.
3. Lowenstein, C. J., and S. H. Snyder. 1992. Nitric oxide, a novel biologic messenger. Cell 70:705.
4. Moncada, S., R. M. J. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109.
5. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051.
6. Stamler, J. S., D. J. Singel, and J. Loscalzo. 1992. Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898.
7. Adams, L. B., J. B. Hibbs, R. R. Taintor, and J. L. Krahenbuhl. 1990. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. J. Immunol. 144:2725.
8. Green S. J., and C. A. Nacy. 1993. Antimicrobial and immunopathologic effects of cytokine-induced nitric oxide synthesis. Curr. Opin. Infect. Dis. 6:384.
9. Ignarro, L. J., H. Lipton, J. C. Edwards, W. H. Baricos, A. L. Hyman, P. J. Kadowitz, and C. A. Gruetter. 1981. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediated. J. Exp. Pharmacol. Ther. 218:739.
10. Ignarro, L. J., C. A. Gruetter, A. L. Hyman, and P. J. Kadowitz. 1983. Molecular mechanisms of vasodilatation. In Dopamine Receptor Agonist. G. Poste and S. T. Crooke, eds. Plenum, New York, p. 259.
11. James, S. L., and J. Glaven. 1989. Macrophages cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143:4208.
12. Vincendeau, P., and S. Daulouède. 1991. Macrophages cytostatic effect on Trypanosoma musculi involves an L-arginine-dependent mechanism. J. Immunol. 146:4338.
13. Blasi, E., L. Pitzurra, M. Puliti, A. R. Chimienti, R. Mazolla, R. Barluzzi, and F. Bistoni. 1995. Differential susceptibility of yeast and hyphal forms of Candida albicans to macrophage-derived nitrogen-containing compounds. Infect. Immun. 63:1806.
14. Keaney, J. F., Jr., D. I. Simon, J. S. Stamler, O. Jaraki, J. Scharfstein, J. A. Vita, and J. Loscalzo. 1993. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J. Clin. Invest. 91:1582.
15. G-hydroxy-L-arginine-nitric oxide adduct. Proc. Natl. Acad. Sci. USA 92:4671.
16. Stamler, J. S., D. I. Simon, O. Jaraki, J. A. Osborne, D. I. Simon, J. Keaney, J. Vita, D. Singel, C. R. Valeri, and J. Loscalzo. 1992. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc. Natl. Acad. Sci. USA 89:7674.
17. Vincendeau, P., and M. Daëron. 1989. Trypanosoma musculi co-express several receptors binding rodent IgM, IgE, and IgG subclasses. J. Immunol. 142:1702.
18. Harlow, E., and D. Lane. 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Press, Cold Spring Harbor, NY, p. 84.
19. Geffard, M., A. M. Heinrich-Rock, J. Dulluc, and P. Seguela. 1985. Antisera against small neurotransmitter-like molecules. Neurochem Int. 7:403.
20. Stamler, J. S., D. I. Simon, O. Jaraki, J. A. Osborne, S. Francis, M. Mullins, D. Singel, and J. Loscalzo. 1992. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc. Natl. Acad. Sci. USA 89:8087.
21. Saville, B. 1958. A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83:670.
22. Geffard, M., R. M. Buijs, P. Seguela, C. W. Pool, and M. Le Moal. 1984. First demonstration of highly specific and sensitive antibodies against dopamine. Brain Res. 294:161.
23. Geffard, M., A. Mc Rae-Degueurce, and M. L. Souan. 1985. Immunocytochemical detection of acetylcholine in the rat central nervous system. Science 229:77.
24. Campistron, G., M. Geffard, and R. Buijs. 1986. Immunological approach to the detection of taurine and immunocytochemical results. J. Neurochem. 46:862.
25. Engvall, E., and P. Perlmann. 1972. Enzyme-linked immunosorbent assay, ELISA: quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J. Immunol. 109:129.
26. Hageman, R. H., and A. J. Reed. 1980. Nitrate reductase from higher plants. Methods Enzymol. 40:427.
27. Lepoivre, M., F. Boudbid, and J. F. Petit. 1989. Antiproliferative activity of interferon combined with lipopolysaccharide on murine adenocarcinoma: dependence on an L-arginine metabolism with production of nitrite and citrulline. Cancer Res. 49:1970.
28. Vincendeau, P., S. Daulouède, B. Veyret, M. L. Darde, B. Bouteille, and J. L. Lemersre. 1992. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp. Parasitol. 75:353.
29. Lucas, R., S. Magez, R. De Leys, L. Fransen, J. P. Scheerlinck, M. Rampelberg, E. Sablon, and P. De Baetselier. 1994. Mapping the lectin-like activity to tumor necrosis factor. Science 263:814.
30. Blackwell, J. M., and J. Alexander. 1983. The macrophage and parasitic protozoa. Trans. R. Soc. Trop. Med. Hyg. 77:636.
31. Albright, J. W., and J. F. Albright. 1981. Differences in resistance to Typanosoma musculi infection among strains of inbred mice. Infect. Immun. 33:364.
32. Evans, T. G., L. Thai, D. L. Granger, and J. B. Hibbs, Jr. 1993. Effect of in vivo inhibition of nitric oxide production in murine leishmaniasis. J. Immunol. 151: 907.
33. Wei, X. Q., I. G. Charles, A. Smith, J. Ure, G. J. Feng, F. P. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408.
34. Grosskinsky, C. M., and B. A. Askonas. 1981. Macrophages as primary target cells and mediators of immune dysfunction in African trypanosomiasis. Infect. Immun. 33:149.
35. Schleifer, K. W., and J. M. Mansfield. 1993. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151:5492.
36. Schleifer, K. W., H. Filutowicz, L. R. Schopf, and J. M. Mansfield. 1993. Characterization of T helper cell responses to the trypanosome variant surface glycoprotein. J. Immunol. 150:2910.
37. Okomo-Assoumou, M. C., S. Daulouède, J. L. Lemesre, A. N'zila-Mouanda, and P. Vincendeau. 1995. Correlation of high serum levels of tumor necrosis factor-α with disease severity in human African trypanosomiasis. Am. J. Trop. Med. Hyg. 53:539.
38. + lymphocytes to interferon-γ secretion: purification, characterization and protective effects in vivo by treatment with a monoclonal antibody against the factor. Scand. J. Immunol. 37:165.
39. Sternberg, J. M., and N. A. Mabbott. 1996. Nitric oxide-mediated suppression of T cell responses during Trypanosoma brucei infection: soluble trypanosome products and interferon-γ are synergistic inducers of nitric oxide synthase. Eur. J. Immunol 26:539.
40. Jacobs, P., D. Radzioch, and M. M. Stevenson. 1995. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J. Immunol. 155:5306.
41. 2 reaction. Chem. Res. Toxicol. 7:519.
42. Laurent, M., M. Lepoivre, and J. P. Tenu. 1996. Kinetic modeling of the nitric oxide gradient generated in vitro by adherent cells expressing inducible nitric oxide synthase. Biochem. J. 314:109.
43. Stamler, J. S., D. I. Simon, J. A. Osborne, S. Francis, M. Mullins, O. Jaraki, D. J. Singel, and J. Loscalzo. 1992. S-nitrosylation of proteins by nitric oxide: synthesis and characterization of novel biologically active compounds. Proc. Natl. Acad. Sci. USA 89:444.
44. Green, S. J., M. S. Meltzer, J. B. Hibbs, Jr., and C. A. Nacy. 1990. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:178.
45. Liew, F. Y., S. Millott, C. Parkinson, R. M. J. Palmer, and S. Moncada. 1990. Macrophages killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. J. Immunol. 144:4794.
46. Albright, J. W., J. M. Stewart, P. S. Latham, and J. F. Albright. 1994. Antibody-facilitated macrophage killing of Trypanosoma musculi is an extracellular process as studied in several variations of an analytical system. J. Leukocyte Biol. 56:636.
47. Scharfstein, J. S., J. F. Keaney, Jr., A. Slivka, G. N. Welch, J. A. Vita, J. S. Stamler, and J. Loscalzo. 1994. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J. Clin. Invest. 94:1432.
48. Ignarro, L. J. 1991. Signal transduction mechanisms involving nitric oxide. Biochem. Pharmacol. 41:485.
49. Roy, B., M. Lepoivre, Y. Henry, and M. Fontecave. 1995. Inhibition of ribonucleotide reductase by nitric oxide derived from thinitrites: reversible modifications of both subunits. Biochemistry 34:5411.
50. Beckmann, J. S., Y. Z. Ye, P. G. Anderson, J. Chen, M. A. Accavitti, M. M. Tarpey, and C. R. White. 1994. Extensive nitration of protein tyrosine in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler 375:81.
51. Ischiropoulos, H., and A. B. Al-Mehdi. 1995. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 364:279.
52. Geffard, M., P. Seguela, and A. M. Heinrich-Rock. 1984. Antisera against catecholamines: specificity studies and physicochemical data for anti-dopamine and anti-p-tyramine antibodies. Mol. Immunol. 21:515.
53. Chagnaud, J. L., S. Faiderbe, and M. Geffard. 1992. Identification and characterization of IgA in sera of patients with mammary tumours. Int. J. Cancer 50: 395.
54. Dugas, B., D. Mossalayi, C. Damais, and J. P. Kolb. 1995. Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol. Today 16:574.
55. Vouldoukis, I., V. Riveros-Moreno, B. Dugas, F. Ouaaz, P. Bécherel, P. Debré, S. Moncada, and D. Mossalayi. 1995. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the FcεRII/ CD23 surface antigen. Proc. Natl Acad. Sci. USA 92:7804.
56. Bukrinsky, M. I., H. S. L. M. Nottet, H. Schmidtmayerova, L. Dubrovsky, C. R. Flanagan, M. E. Mullins, S. A. Lipton, and H. E. Gendelman. 1995. Regulation of nitric oxide synthase activity in human immunodefiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J. Exp. Med. 181:735.
57. Lipton, S. A., and H. Gendelman. 1995. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332:934.
58. Esteban, F., J. Omez-Jimémer, M. C. Martin, J. C. Ruiz, X. Nuvials, J. L. Garcia-Allut, R. Sauri, J. E. Murio, M. Mourelle, R. M. Segura, A. Mora, R. Peracaula, C. Margarit, and A. Salgado. 1995. Nitric oxide and hepatic ischemic injury in human orthotopic liver transplantation. Transplant. Proc. 27:2283.